scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1365-2893.1999.00184.X |
P698 | PubMed publication ID | 10607253 |
P50 | author | Ferruccio Bonino | Q37828551 |
Gioacchino Leandro | Q42705700 | ||
P2093 | author name string | G Mancia | |
M R Brunetto | |||
G Bellati | |||
G Idéo | |||
F Bissoli | |||
L Roffi | |||
G Colloredo | |||
A Scalori | |||
B Brugnetti | |||
E Civardi | |||
P2860 | cites work | Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region | Q27861003 |
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 | ||
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources | Q29620774 | ||
Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables. | Q34377809 | ||
Side effects of alpha interferon | Q38745781 | ||
Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment | Q39507207 | ||
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study | Q42980911 | ||
Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. | Q42980987 | ||
Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy | Q42982517 | ||
Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha | Q42982978 | ||
Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison | Q42985824 | ||
Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection | Q43035211 | ||
Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C | Q43038103 | ||
Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon | Q43040128 | ||
Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy | Q43040510 | ||
Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon | Q43041718 | ||
Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C. | Q43049010 | ||
Clinical outcomes after transfusion-associated hepatitis C. | Q44746801 | ||
The long-term pathological evolution of chronic hepatitis C. | Q44765507 | ||
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). | Q45852358 | ||
A proposed system for the nomenclature of hepatitis C viral genotypes | Q57205742 | ||
Interferon for non-A, non-B chronic hepatitis | Q58803541 | ||
P433 | issue | 5 | |
P921 | main subject | Hepatitis C virus | Q708693 |
P304 | page(s) | 373-380 | |
P577 | publication date | 1999-09-01 | |
P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
P1476 | title | Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy | |
P478 | volume | 6 |
Search more.